Live
- Poonam Prabhakar challenges Bandi Sanjay to tell what BJP has done in past decade
- 27pc spike in anti-vaccine posts on X after Covid jabs were available: Study
- Elon Musk visits China, likely to promote Tesla's driverless tech: Report
- Sri Lanka signals shift in interest as Indian firm to jointly manage China-built airport close to strategic Hambantota port
- Iran unveils new 'kamikaze' drone
- Bangladesh faces longest-ever heatwave
- UP: Samajwadi Party faces its biggest challenge in third phase polls
- UK PM Sunak again refuses to rule out July general election
- Russia, Ukraine launch drone strikes
- ‘Lovely experienced personal pain over last 2 to 3 months', says Congress leader Sandeep Dikshit
GVK Bio, LifeArc advance research in medicine
GVK BIO, a global contract research and development organisation (CRDO), and LifeArc, a UK-based medical research charity, on Wednesday
Hyderabad: GVK BIO, a global contract research and development organisation (CRDO), and LifeArc, a UK-based medical research charity, on Wednesday said they completed 10 years of partnership, wherein the collaboration was aimed at advancing research ideas into potential medicines.
LifeArc said its approach involves partnerships with academia and service organisations to advance discoveries into promising medicines.
"Our scientific teams focus their efforts on modulating targets with therapeutic potential in diseases where there is patient need.
The GVK Bio team has assisted in synthesizing complex molecules rapidly and cost-effectively to drive improvement in efficacy and safety," LifeArc added.
Melanie Lee, CEO, LifeArc, said: "At LifeArc, we are committed to translating scientific innovation to benefit patients.
Our partnership with GVK Bio is an example of how shared goals and collaboration can create value."
Under this partnership, medicines such as Keytruda, Tysabri, Entyvio among others have been delivered.
